Insomnia Pharmacological Treatment Market Research Report by Treatment (Over-the-Counter Sleep Aids and Prescription Sleep Aids) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This...
Insomnia - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Insomnia - Pipeline Review, H2 2020, provides an overview of the Insomnia (Central Nervous System) pipeline landscape. Insomnia is a sleep disorder that is characterized by difficulty falling...
Orexin Receptor Type 1 - Pipeline Review, H2 2020 Summary Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) pipeline Target constitutes close to 15 molecules. The latest report Orexin Receptor Type 1 - Pipeline Review, H2 2020, outlays comprehensive information on the Orexin Receptor...
Nociceptin Receptor - Pipeline Review, H2 2020 Summary According to the recently published report ’Nociceptin Receptor - Pipeline Review, H2 2020’; Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) pipeline Target constitutes close to 17 molecules. Out of...
The outbreak of Coronavirus (COVID-19) and the subsequent lockdown have had a strong effect on consumer health in Belgium. Thus, there have been significant switches from category to category, as well as one distribution channel to another due to strong restrictions on retailing. Consumer Health in Belgium report offers a comprehensive...
China’s demand for Sleep Disorder Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...
The impact of the 19 pandemic on sales of consumer health products in Saudi Arabia was not as pronounced as in many other countries for the simple reason that many OTC products in Saudi Arabia are covered by health insurance policies. This means that many people rarely, if ever purchase their OTC products at full price via normal retail channels. Consumer...
The outbreak of COVID-19 in South Korea is not predicted to increase growth in 2020, with value growth of 3% expected for the year, compared to value growth of 5% recorded in 2019. As South Korea did not have an enforced lockdown, sales were not impacted by high levels of stockpiling that was seen in other countries Consumer Health...
The outbreak of COVID-19 is expected to lead to an increase in growth for 2020, with 4% value growth predicted, compared to 3% in 2019. Much of this higher growth will be due to panic buying and stockpiling of goods, with consumers in Q1 and Q2 of 2020, keen to ensure they had goods they deemed as essentials in the home. Consumer Health...
The Europe addictions therapeutics market is expected to reach US$ 2,147.19 million by 2027 from US$ 1,410.85 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020 to 2027. The growth of the market is attributed to the rising approval of new drugs and launch of digital therapeutics to treat addiction, and increasing...